Maternal adipokines longitudinally measured across pregnancy and their associations with neonatal size, length, and adiposity

Stefanie N. Hinkle, Shristi Rawal, Danping Liu, Jinbo Chen, Michael Y. Tsai, Cuilin Zhang

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Background/objectives: Maternal obesity impacts fetal growth as early as second trimester of pregnancy, yet little is known about the molecular mechanisms involved. We aimed to examine associations between maternal adipokines throughout pregnancy and neonatal size by prepregnancy obesity status. Methods: In a prospective cohort of 2802 U.S. pregnant women from the NICHD Fetal Growth Studies-Singleton Cohort (2009–2013), biospecimens were analyzed in a matched case−control subset of 321 women. Blood was collected at 10–14, 15–26 (fasting), 23–31, and 33–39 gestational weeks. Plasma leptin and soluble leptin receptor (sOB-R) and total and high-molecular-weight (HMW)-adiponectin were measured. Free leptin was calculated as leptin/sOB-R. Birthweight was abstracted from medical records. Neonatal length and skinfolds were measured. Results: Leptin and sOB-R in late pregnancy tended to be positively and negatively associated with neonatal length, respectively, while free leptin throughout pregnancy tended to be positively associated with length. Free leptin associations with neonatal length were differential by obesity (i.e., inversely among women without obesity and positively among women with obesity). A per unit increase in free leptin at 33–39 weeks was associated with a shorter neonatal length by −0.55 cm (95%CI, −0.83, −0.28) in women without obesity and longer length by 0.49 cm (95%CI, 0.34, 0.65) in women with obesity. HMW-adiponectin at 33–39 weeks was inversely associated with neonatal length (β = −1.29 cm; 95%CI, −1.74, −0.85) and skinfold thickness (β = −1.46 mm; 95%CI, −1.58, −0.56) among women with obesity. Free leptin across pregnancy tended to be negatively associated with neonatal skinfold thickness among women without obesity, while free leptin in early pregnancy was positively associated with skinfold thickness. Conclusions: Maternal adipokines were associated with multiple pathways that influence neonatal size including length and adiposity, which differed in timing across pregnancy and by prepregnancy obesity. These findings provide new potential insights into mechanisms and timing by which maternal obesity may impact fetal growth.

Original languageEnglish (US)
Pages (from-to)1422-1434
Number of pages13
JournalInternational Journal of Obesity
Issue number7
StatePublished - Jul 1 2019

Bibliographical note

Funding Information:
Funding This research was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development intramural funding as well as the American Recovery and Reinvestment Act funding (contract numbers HHSN275200800013C, HHSN275200800002I, HHSN 27500006, HHSN275200800003IC, HHSN275200800014C, HHSN2752 00800012C, HHSN275200800028C, HHSN275201000009C, and HHSN 275201000001Z).

Publisher Copyright:
© 2018, Springer Nature Limited.


Dive into the research topics of 'Maternal adipokines longitudinally measured across pregnancy and their associations with neonatal size, length, and adiposity'. Together they form a unique fingerprint.

Cite this